PC12 Next-generation Assisted Reproductive Technology (ART): CME Personalized Reproductive Medical Management Developed in Cooperation with MEFS
Faculty
Johnny Awwad, M.D. (Co-Chair)
American University of Beirut
Mohamed Aboulghar, M.D. (Co-Chair)
Egyptian IVF Center
Alan Penzias, M.D.
Boston IVF
Matheus Roque, M.D., Ph.D.
ORIGEN - Center for Reproductive Medicine, Rio de Janeiro, Brazil
Needs Assessment and Description
Significant advancement in the field of assisted reproduction lately has favored personalizing treatment recommendations on the basis of individual patient characteristics. As the number of clinical, hormonal, and genetic biomarkers available to physicians has increased, predictive models that integrate multiple variables have become attractive strategies to guide medical decision-making for the purpose of bringing greater efficiency and safety to reproductive practices. The burden of medical information has grown so rapidly and controversially over the past few years that reaching a level of understanding has become challenging and confusing to the individual physician. This activity appraises scientific evidence which evaluates the pros and cons of current reproductive practices with the aim of developing best practice models while leveraging the significance of relevant biomarkers and the contribution of clinical variables. Through an active learning format that evolves around team-based problem-solving of clinical vignettes, this course will help clinicians, embryologists, scientists, and allied health professionals update and gain basic and advanced knowledge of treatment and management protocols based on individual patient characteristics.
ACGME Competency
Patient Care
Medical Knowledge
Learning Objectives
At the conclusion of this course, participants should be able to:
1- Design ovarian stimulation protocols tailored to patients’ individual characteristics.
2- Demonstrate safe strategies to trigger final oocyte maturation without compromising outcome.
3- Identify clinical parameters associated with improved outcomes related to freeze-all policy.
4- Evaluate the advantages of a day-5 versus day-3 embryo transfer.
5- Develop a management approach to improve the use of elective single-embryo transfer while maximizing benefit.
Due to the team-based learning format, this course is limited to 100 participants.
